Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring. The company is based in Redwood City, California, with European headquarters in Geneva, Switzerland.
Redwood City, 501-1000 employees
Leading the battle against cancer, together
Exact Sciences and Genomic Health have come together, taking earlier cancer detection and treatment insights and monitoring to the next level. By combining our portfolio of products, we are continuing our relentless pursuit of innovative solutions of earlier detection and smarter answers.